Catelyn Coyle1, Helena Kwakwa2. 1. National Nursing Centers Consortium, Philadelphia, PA. 2. Philadelphia Department of Public Health, Clinical HIV Services, Philadelphia, PA.
Abstract
OBJECTIVE: Despite common risk factors, screening for hepatitis C virus (HCV) and HIV at the same time as part of routine medical care (dual-routine HCV/HIV testing) is not commonly implemented in the United States. This study examined improvements in feasibility of implementation, screening increase, and linkage to care when a dual-routine HCV/HIV testing model was integrated into routine primary care. METHODS: National Nursing Centers Consortium implemented a dual-routine HCV/HIV testing model at four community health centers in Philadelphia, Pennsylvania, on September 1, 2013. Routine HCV and opt-out HIV testing replaced the routine HCV and opt-in HIV testing model through medical assistant-led, laboratory-based testing and electronic medical record modification to prompt, track, report, and facilitate reimbursement for tests performed on uninsured individuals. This study examined testing, seropositivity, and linkage-to-care comparison data for the nine months before (December 1, 2012-August 31, 2013) and after (September 1, 2013-May 31, 2014) implementation of the dual-routine HCV/HIV testing model. RESULTS: A total of 1,526 HCV and 1,731 HIV tests were performed before, and 1,888 HCV and 3,890 HIV tests were performed after dual-routine testing implementation, resulting in a 23.7% increase in HCV tests and a 124.7% increase in HIV tests. A total of 70 currently HCV-infected and four new HIV-seropositive patients vs. 101 HCV-infected and 13 new HIV-seropositive patients were identified during these two periods, representing increases of 44.3% for HCV antibody-positive and RNA-positive tests and 225.0% for HIV-positive tests. Linkage to care increased from 27 currently infected HCV--positive and one HIV-positive patient pre-dual-routine testing to 39 HCV--positive and nine HIV-positive patients post-dual-routine testing. CONCLUSION: The dual-routine HCV/HIV testing model shows that integrating dual-routine testing in a primary care setting is possible and leads to increased HCV and HIV screening, enhanced seropositivity diagnosis, and improved linkage to care.
OBJECTIVE: Despite common risk factors, screening for hepatitis C virus (HCV) and HIV at the same time as part of routine medical care (dual-routine HCV/HIV testing) is not commonly implemented in the United States. This study examined improvements in feasibility of implementation, screening increase, and linkage to care when a dual-routine HCV/HIV testing model was integrated into routine primary care. METHODS: National Nursing Centers Consortium implemented a dual-routine HCV/HIV testing model at four community health centers in Philadelphia, Pennsylvania, on September 1, 2013. Routine HCV and opt-out HIV testing replaced the routine HCV and opt-in HIV testing model through medical assistant-led, laboratory-based testing and electronic medical record modification to prompt, track, report, and facilitate reimbursement for tests performed on uninsured individuals. This study examined testing, seropositivity, and linkage-to-care comparison data for the nine months before (December 1, 2012-August 31, 2013) and after (September 1, 2013-May 31, 2014) implementation of the dual-routine HCV/HIV testing model. RESULTS: A total of 1,526 HCV and 1,731 HIV tests were performed before, and 1,888 HCV and 3,890 HIV tests were performed after dual-routine testing implementation, resulting in a 23.7% increase in HCV tests and a 124.7% increase in HIV tests. A total of 70 currently HCV-infected and four new HIV-seropositivepatients vs. 101 HCV-infected and 13 new HIV-seropositivepatients were identified during these two periods, representing increases of 44.3% for HCV antibody-positive and RNA-positive tests and 225.0% for HIV-positive tests. Linkage to care increased from 27 currently infected HCV--positive and one HIV-positive patient pre-dual-routine testing to 39 HCV--positive and nine HIV-positive patients post-dual-routine testing. CONCLUSION: The dual-routine HCV/HIV testing model shows that integrating dual-routine testing in a primary care setting is possible and leads to increased HCV and HIV screening, enhanced seropositivity diagnosis, and improved linkage to care.
Authors: Matthew J Mimiaga; Carey V Johnson; Sari L Reisner; Rodney Vanderwarker; Kenneth H Mayer Journal: Public Health Rep Date: 2011 Sep-Oct Impact factor: 2.792
Authors: Stephen F Morin; Jeffrey A Kelly; Edwin D Charlebois; Robert H Remien; Mary J Rotheram-Borus; Paul D Cleary Journal: J Acquir Immune Defic Syndr Date: 2011-07-01 Impact factor: 3.731
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Catelyn Coyle; Anne C Moorman; Tyler Bartholomew; Gary Klein; Helena Kwakwa; Shruti H Mehta; Deborah Holtzman Journal: Hepatology Date: 2019-03-26 Impact factor: 17.425
Authors: Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie Journal: Infect Dis Clin North Am Date: 2018-06 Impact factor: 5.982
Authors: Carmen N Burrell; Melinda J Sharon; Stephen Davis; Judith Feinberg; Elena M Wojcik; Julia Nist; Owen Lander; Valerie Boley; Justin Burns; Ian B K Martin Journal: BMC Health Serv Res Date: 2021-05-29 Impact factor: 2.655
Authors: Joseph D Tucker; Kathrine Meyers; John Best; Karyn Kaplan; Razia Pendse; Kevin A Fenton; Isabelle Andrieux-Meyer; Carmen Figueroa; Pedro Goicochea; Charles Gore; Azumi Ishizaki; Giten Khwairakpam; Veronica Miller; Antons Mozalevskis; Michael Ninburg; Ponsiano Ocama; Rosanna Peeling; Nick Walsh; Massimo G Colombo; Philippa Easterbrook Journal: BMC Infect Dis Date: 2017-11-01 Impact factor: 3.090
Authors: Matthew R Golden; Jeffery Duchin; Lisa D Chew; Jane H Huntington; Nancy Sugg; Sara Jackson; Aric Lane; Monica Pecha; Elizabeth Barash; John Scott Journal: Open Forum Infect Dis Date: 2017-04-06 Impact factor: 3.835